Cardlytics Inc
For the period ended Sep 30, 2024. Filed Nov 6, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 6, 2024
CDLX$1.63-10.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations (Unaudited)
(Amounts in thousands, except per share amounts)
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Revenue | $67,057 | $79,005 | $204,301 | $220,037 |
| Costs and expenses: | ||||
| Partner Share and other third-party costs | 30,675 | 36,144 | 94,476 | 108,698 |
| Delivery costs | 7,830 | 7,012 | 21,664 | 20,451 |
| Sales and marketing expense | 13,163 | 14,161 | 41,306 | 43,314 |
| Research and development expense | 13,194 | 12,430 | 39,712 | 38,841 |
| General and administration expense | 12,076 | 15,561 | 42,712 | 44,907 |
| Acquisition, integration and divestiture costs (benefit) | — | 78 | 162 | (8,146) |
| Change in contingent consideration | 100 | 8,281 | 110 | (15,045) |
| Impairment of goodwill and intangible assets | 131,595 | — | 131,595 | — |
| Depreciation and amortization expense | 6,970 | 5,990 | 19,749 | 19,765 |
| Total costs and expenses | 215,603 | 99,657 | 391,486 | 252,785 |
| Operating Loss | (148,546) | (20,652) | (187,185) | (32,748) |
| Other (expense) income: | ||||
| Interest expense, net | (1,479) | (915) | (3,859) | (1,497) |
| Foreign currency gain (loss) | 4,843 | (2,399) | 4,312 | 379 |
| Gain on debt extinguishment | — | — | 13,017 | — |
| Total other income (expense) | 3,364 | (3,314) | 13,470 | (1,118) |
| Loss before income taxes | (145,182) | (23,966) | (173,715) | (33,866) |
| Net Loss | $(145,182) | $(23,966) | $(173,715) | $(33,866) |
| Net Loss per share, basic and diluted | $(2.90) | $(0.63) | $(3.66) | $(0.95) |
| Weighted-average common shares outstanding, basic and diluted | 50,028 | 37,982 | 47,469 | 35,502 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.